All-trans retinoic acid가 면역세포의 Toll-like receptor 5 발현에 미치는 영향
Effects of all-trans retinoic acid on expression of Toll-like receptor 5 on immune cells
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Introduction: TLR-5, a member of the toll-like receptor (TLR) family, is a element of the type I transmembrane receptors, which are characterized by an intracellular signaling domain homolog to the interleukin-1 receptor. These receptors recognize microbial components, particularly bacterial flagellin. All-trans retinoic acid (atRA, tretinoin), a natural metabolite of vitamin A, acts as a growth and differentiation factor in many tissues, and is also needed for immune functions. In this study, THP-1 human macrophage-monocytes were used to examine the mechanisms by which atRA regulated the expression of TLR-5. Because the molecular mechanism underlying this regulation at the transcriptional level is also unclear, this study examined which putative transcription factors are responsible for TLR-5 expression by atRA in immune cells. Materials and Methods: This study examined whether atRA induces the expression of TLR-5 in THP-1 cells using reverse transcription-polymerase chain reaction (RT-PCR), and which transcription factors are involved in regulating the TLR-5 promoter in RAW264.7 cells using a reporter assay system. Western blot analysis was used to determine which signal pathway is involved in the expression of TLR-5 in atRA-treated THP-1 cells. Results: atRA at a concentration of 10 nM greatly induced the expression of TLR-5 in THP-1 cells. Human TLR-5 promoter contains three Sp-1/GC binding sites around -50 bp and two NF-kB binding sites at -380 bp and -160 bp from the transcriptional start site of the TLR-5 gene. Sp-1/GC is primarily responsible for the constitutive TLR-5 expression, and may also contribute to NF-kB at -160 bp to induce TLR-5 after atRA stimulation in THP-1 cells. The role of NF-kB in TLR-5 expression was further confirmed by inhibitor pyrrolidine dithiocarbamate (PDTC) experiments, which greatly reduced the TLR-5 transcription by 70-80%. Conclusion: atRA induces the expression of the human TLR-5 gene and NF-kB is a critical transcription factor for the atRA-induced expression of TLR-5. Accordingly, it is conceivable that retinoids are required for adequate innate and adaptive immune responses to agents of infectious diseases. atRA and various synthetic retinoids have been used therapeutically in human diseases, such as leukemia and other cancers due to the antiproliferative and apoptosis inducing effects of retinoids. Therefore, understanding the molecular regulatory mechanism of TLR-5 may assist in the design of alternative strategies for the treatment of infectious diseases, leukemia and cancers.
Abstract
Introduction: TLR-5, a member of the toll-like receptor (TLR) family, is a element of the type I transmembrane receptors, which are characterized by an intracellular signaling domain homolog to the interleukin-1 receptor. These receptors recognize microbial components, particularly bacterial flagellin. All-trans retinoic acid (atRA, tretinoin), a natural metabolite of vitamin A, acts as a growth and differentiation factor in many tissues, and is also needed for immune functions. In this study, THP-1 human macrophage-monocytes were used to examine the mechanisms by which atRA regulated the expression of TLR-5. Because the molecular mechanism underlying this regulation at the transcriptional level is also unclear, this study examined which putative transcription factors are responsible for TLR-5 expression by atRA in immune cells. Materials and Methods: This study examined whether atRA induces the expression of TLR-5 in THP-1 cells using reverse transcription-polymerase chain reaction (RT-PCR), and which transcription factors are involved in regulating the TLR-5 promoter in RAW264.7 cells using a reporter assay system. Western blot analysis was used to determine which signal pathway is involved in the expression of TLR-5 in atRA-treated THP-1 cells. Results: atRA at a concentration of 10 nM greatly induced the expression of TLR-5 in THP-1 cells. Human TLR-5 promoter contains three Sp-1/GC binding sites around -50 bp and two NF-kB binding sites at -380 bp and -160 bp from the transcriptional start site of the TLR-5 gene. Sp-1/GC is primarily responsible for the constitutive TLR-5 expression, and may also contribute to NF-kB at -160 bp to induce TLR-5 after atRA stimulation in THP-1 cells. The role of NF-kB in TLR-5 expression was further confirmed by inhibitor pyrrolidine dithiocarbamate (PDTC) experiments, which greatly reduced the TLR-5 transcription by 70-80%. Conclusion: atRA induces the expression of the human TLR-5 gene and NF-kB is a critical transcription factor for the atRA-induced expression of TLR-5. Accordingly, it is conceivable that retinoids are required for adequate innate and adaptive immune responses to agents of infectious diseases. atRA and various synthetic retinoids have been used therapeutically in human diseases, such as leukemia and other cancers due to the antiproliferative and apoptosis inducing effects of retinoids. Therefore, understanding the molecular regulatory mechanism of TLR-5 may assist in the design of alternative strategies for the treatment of infectious diseases, leukemia and cancers.
참고문헌 (28)
- Hashimoto C, "The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein", Cell, 52, pp.269~279 (1988)
- Medzhitov R, "A human homologue of the Drosophila Toll protein signals activation of adaptive immunity", Nature, 388, pp.394~397 (1997)
- Kaisho T, "Toll-like receptor function and signaling", J Allergy Clin Immunol, 117, pp.979~987 (2006)
- Lee SJ, "Toll-like receptors and inflammation in the CNS", Curr Drug Targets Inflamm Allergy, 1, pp.181~191 (2002)
- Goodman DS, "Vitamin A and retinoids in health and disease", N Engl J Med, 310, pp.1023~1031 (1984)
- Lotan R, "Immunomodulatory effects of retinoids", J Nutr Growth Cancer, 3, pp.57~65 (1986)
- Lotan R, "Retinoids in cancer chemoprevention", FASEB J, 10, pp.1031~1039 (1996)
- Hofmann C, "Retinoids in development. In: The retinoids: biology, chemistry and medicine. 2nd ed", pp.387~442 (1994), Raven Press
- Israel H, "The effects of retinoic acid on immunoglobulin synthesis by human cord blood mononuclear cells", Clin Immunol Immunopathol, 59, pp.417~425 (1991)
- Wang W, "The effects of retinoic acid on in vitro immunoglobulin synthesis by cord blood and adult peripheral blood mononuclear cells", Cell Immunol, 148, pp.291~300 (1993)
- Ballow M, "Modulation of B-cell immunoglobulin synthesis by retinoic acid", Clin Immunol Immunopathol, 80, pp.73~81 (1996)
- Cantorna MT, "In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function", J Immunol, 152, pp.1515~1522 (1994)
- Racke MK, "Retinoid treatment of experimental allergic encephalomyelitis IL-4 production correlates with improved disease course", J Immunol, 154, pp.450~458 (1995)
- Stephensen C, "Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway", J Immunol, 168, pp.4495~4503 (2002)
- Lee HY, "All-trans retinoic acid converts E2F into a transcriptional suppressor and inhibits the growth of normal human bronchial epithelial cells through a retinoic acid receptor-dependent signaling pathway", J Clin Invest, 101, pp.1012~1019 (1998)
- Sun SY, "Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells", Oncogene, 19, pp.4513~4522 (2000)
- Wan YJ, "Retinoic acid differentially regulates retinoic acid receptor-mediated pathways in the Hep3B cell line", Exp Cell Res, 238, pp.241~247 (1998)
- Agadir A, "Retinyl methyl ether down-regulates activator protein 1 transcriptional activation in breast cancer cells", Cancer Res, 57, pp.3444~3450 (1997)
- Liu PT, "All-trans Retinoic acid down-regulates TLR2 expression and function", J Immunol, 174, pp.2467~2470 (2005)
- Gudas LJ, "Cellular biology and biochemistry of the retinoids. In: The retinoids: biology, chemistry and medicine. 2nd ed", pp.443~450 (1994), Raven Press
- Ross AC, "Vitamin A and retinoids in antiviral responses", FASEB J, 10, pp.979~985 (1996)
- Ross AC, "Retinoids and the immune system. In: The retinoids: biology, chemistry and medicine. 2nd ed", pp.521~543 (1994), Raven Press
- Ballow M, "The effects of retinoic acid on immunoglobulin synthesis: role of interleukin 6", J Clin Immunol, 16, pp.171~179 (1996)
- Ballow M, "Retinoic acid (RA) induced enhancing effects on immunoglobulin (Ig) synthesis of human B-cells", Pediatr Res, 33, pp.151~ (1993)
- Ballow M, "Retinoic acid-induced modulation of IL-2mRNA production and IL-2 receptor expression on T Cells", Int Arch Allergy Immunol, 113, pp.167~169 (1997)
- Matikainen S, "Retinoic acid enhances IL- 1βexpression in myeloid leukemia cells and in human monocytes", J Immunol, 147, pp.162~167 (1991)
- Blomhoff HK, "Vitamin A is a key regulator for cell growth, cytokine production, and differentiation in normal B cells", J Biol Chem, 267, pp.23988~23992 (1992)
- Chen Q, "Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells Exp", Cell Res, 297, pp.68~81 (2004)